Neuromeka Future Growth
Future criteria checks 2/6
Neuromeka is forecast to grow revenue at 31.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Machinery earnings growth | 58.3% |
Revenue growth rate | 31.3% |
Future return on equity | 15.5% |
Analyst coverage | Low |
Last updated | 05 Nov 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 46,000 | N/A | N/A | 17,000 | 1 |
12/31/2025 | 34,000 | N/A | N/A | 11,000 | 2 |
12/31/2024 | 25,000 | N/A | N/A | 1,000 | 2 |
6/30/2024 | 20,687 | -18,899 | -40,433 | -17,818 | N/A |
3/31/2024 | 16,414 | -21,181 | -43,953 | -15,515 | N/A |
12/31/2023 | 13,743 | -17,654 | -43,035 | -12,434 | N/A |
9/30/2023 | 11,221 | -12,991 | -42,680 | -11,784 | N/A |
6/30/2023 | 9,190 | -10,752 | -23,720 | -10,775 | N/A |
3/31/2023 | 9,396 | -9,033 | -14,375 | -8,511 | N/A |
12/31/2022 | 9,755 | -8,201 | -11,322 | -7,999 | N/A |
9/30/2022 | 7,816 | -4,755 | -9,042 | -7,218 | N/A |
6/30/2022 | 8,911 | -3,845 | -4,039 | -3,572 | N/A |
3/31/2022 | 7,155 | -5,501 | -3,888 | -3,434 | N/A |
12/31/2021 | 7,351 | -6,594 | -1,349 | -1,056 | N/A |
12/31/2020 | 4,066 | -8,271 | -4,315 | -4,016 | N/A |
12/31/2019 | 7,212 | -2,993 | -8,463 | -7,123 | N/A |
12/31/2018 | 3,093 | -9,226 | -6,236 | -5,797 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A348340's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A348340's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A348340's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A348340's revenue (31.3% per year) is forecast to grow faster than the KR market (9.2% per year).
High Growth Revenue: A348340's revenue (31.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A348340's Return on Equity is forecast to be low in 3 years time (15.5%).